Status:
COMPLETED
Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)
Lead Sponsor:
Beckman Coulter, Inc.
Collaborating Sponsors:
Hôpital Raymond Poincaré
Saint-Louis Hospital, Paris, France
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Non-interventional, prospective, monocentric study on the exploration of leukocyte morphological parameters according to the infectious condition and response to corticosteroid therapy of septic patie...
Detailed Description
Sepsis is a major public health issue, caused by an organ disorder related to an immune response not controlled by the infection. Several randomized trials have shown that the combination of glucocor...
Eligibility Criteria
Inclusion
- an infection (known or suspected)
- sepsis
- sepsis + vasopressor
- septic shock
- responders to corticosteroid therapy
- non-responders to corticosteroid therapy
Exclusion
- Pregnant women
- Patients with onco-hematological diseases with the presence of blasts.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT04292431
Start Date
November 1 2019
End Date
December 30 2020
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Raymond Poincaré
Garches, Paris, France, 92380